Publication Name	World Journal of Diabetes
Manuscript ID	6359
Country	Sweden

Received	2013-10-15 10:18
Peer-Review Started	2013-10-16 10:12
To Make the First Decision	2013-11-12 14:29
Return for Revision	2013-11-13 14:58
Revised	2013-11-25 00:44
Second Decision	2013-12-13 13:31
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-12-13 14:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-12-17 18:39
Typeset the Manuscript	2014-02-15 16:54
Publish the Manuscript Online	2014-02-19 15:19

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes
Manuscript Source	Invited Manuscript
All Author List	Bo Ahrén
Funding Agency and Grant Number
Corresponding Author	Dr. Bo Ahrén, Professor, Department of Clinical Sciences Lund, Lund University, B11 BMC, 221 84 Lund, Sweden. bo.ahren@med.lu.se
Key Words	Type 2 diabetes; Glucose lowering; Insulin therapy; Glucagon-like peptide-1 receptor agonists; Dipeptidyl peptidase-4 inhibitors; Incretin therapy; Combination
Core Tip	Incretin therapy (glucagon-like peptide-1 receptor agonists or dipeptidyl peptidase-4 inhibitors) combined with insulin therapy is a glucose-lowering strategy in type 2 diabetes. The combination allows a complementary mode of mechanistic action and, as demonstrated in several clinical trials, is glucose-lowering in association with limited risk for hypoglycemia and weight gain. The combination is a promising strategy in patients in whom metformin with either incretin therapy or basal insulin is insufficient for adequate glycemic control. This article reviews the background and clinical studies on this combination.
Publish Date	2014-02-19 15:19
Citation	Ahrén B. Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes. World J Diabetes 2014; 5(1): 40-51 Available from: URL: http://www.wjgnet.com/1948-9358/full/v5/i1/40.htm DOI: http://dx.doi.org/10.4239/wjd.v5.i1.40
URL	http://www.wjgnet.com/1948-9358/full/v5/i1/40.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i1.40

Full Article (PDF)	WJD-5-40.pdf
Full Article (Word)	WJD-5-40.doc
Manuscript File	6359-Review.docx
Answering Reviewers	6359-Answering reviewers.pdf
Copyright License Agreement	6359-Copyright assignment.pdf
Peer-review Report	6359-Peer review(s).pdf
Scientific Editor Work List	6359-Scientific editor work list.doc